Savolitinib vs. Sunitinib in MET-driven PRCC.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Barretos, Brazil
- Research Site
Curitiba, Brazil
- Research Site
Passo Fundo, Brazil
- Research Site
Pelotas, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Rio de Janeiro, Brazil
- Research Site
São José do Rio Preto, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Bordeaux, France
- Research Site
Vandœuvre-lès-Nancy, France
- Research Site
Villejuif, France
- Research Site
Arezzo, Italy
- Research Site
Meldola, Italy
- Research Site
Milan, Italy
- Research Site
Modena, Italy
- Research Site
Orbassano, Italy
- Research Site
Pavia, Italy
- Research Site
Roma, Italy
- Research Site
Krasnoyarsk, Russia
- Research Site
Moscow, Russia
- Research Site
Moscow, Russia
- Research Site
Moscow, Russia
- Research Site
Moscow, Russia
- Research Site
Murmansk, Russia
- Research Site
Nizhny Novgorod, Russia
- Research Site
Obninsk, Russia
- Research Site
Omsk, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Volgograd, Russia
- Research Site
Daejeon, South Korea
- Research Site
Goyang-si, South Korea
- Research Site
Hwasun-gun, South Korea
- Research Site
Incheon, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jul 2017
- Primary completion
- 18 Aug 2019
- Completion
- 31 Dec 2026
- Last update posted
- 14 Apr 2026
- Registered enrollment
- 60
- Registry id
- NCT03091192
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.